Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities.  Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.

Biotechnology

Symphogen

Symphogen's headquarters in Ballerup, Denmark

This department focuses on the management and execution of technical processes and support functions.

Technical Operations

The Scientific Team at Symphogen is dedicated to advancing oncology treatments through rigorous research and development. Comprised of experts in monoclonal antibody (mAb) technologies, they focus on creating and validating differentiated mAb and mAb mixture product candidates. The team collaborates on everything from target biology and cell culture to analytical coordination and drug formulation, aiming to deliver precision-medicine solutions for biomarker-selected patient populations.

Scientific Team

The Laboratory Team at Symphogen is responsible for conducting critical experimental work, including developing and optimizing monoclonal antibody (mAb) and mAb mixture product candidates. Their roles encompass antibody discovery, lab automation, analytical assessments, and quality assurance, all geared towards advancing the company's innovative oncology pipeline through precise, data-driven research.

Laboratory Team

The Leadership Team at Symphogen is responsible for setting the strategic direction and overseeing the execution of the company's clinical-stage antibody oncology initiatives. Comprising key executives and principal scientists, this team drives innovation in monoclonal antibody research and development, ensures alignment with precision medicine goals, and fosters collaboration across departments to enhance pipeline performance and operational efficiency. Their leadership is pivotal in navigating regulatory landscapes, managing resources, and advancing Symphogen's mission to improve patient outcomes through targeted therapeutic solutions.

Leadership Team

This department focuses on innovative research and the development of new products and technologies.

Research and Development

The Senior Management Team at Symphogen provides strategic leadership and direction to the company, ensuring alignment with its mission to develop innovative antibody oncology therapies. This team oversees key aspects of the organization, including scientific research and development, manufacturing, financial management, human resources, and operations. Their collective expertise and decisions drive the company's progress in its pre-clinical and clinical pipelines, aiming to deliver life-changing treatments for patients.

People (9)

Jobs (0)

Other teams

Scientific Team

Laboratory Team

Leadership Team

Research and Development

Senior Management Team